Toronto Dominion Bank’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$82.8M Buy
90,000
+65,000
+260% +$65.9M 0.12% 159
2025
Q4
$26.9M Sell
25,000
-12,500
-33% -$12M 0.04% 379
2025
Q3
$28.6M Buy
+37,500
New +$27.9M 0.04% 345
2025
Q1
Sell
-1,100
Closed -$849K 1624
2024
Q4
$849K Buy
+1,100
New +$911K ﹤0.01% 1093
2019
Q2
Sell
-38,700
Closed -$5.02M 1628
2019
Q1
$5.02M Buy
+38,700
New +$4.71M 0.01% 692

Other funds holding LLY

Toronto Dominion Bank's LLY Position: Q1 2026 in Review

Toronto Dominion Bank reduced its Eli Lilly (LLY) stake by 14% in Q1 2026, selling an estimated $56.1M and leaving 329,370 shares worth $303M. The position accounts for 0.43% of the portfolio, ranked #43.

Toronto Dominion Bank first reported a position in LLY in Q2 2013 and has held it in 52 quarters since. The position peaked at $413M in Q4 2025. 4,356 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Toronto Dominion Bank held 329,370 shares of Eli Lilly worth $303M as of Q1 2026.
  • Toronto Dominion Bank sold 55,341 Eli Lilly shares in Q1 2026, an estimated $56.1M.
  • Eli Lilly made up 0.43% of Toronto Dominion Bank's portfolio in Q1 2026, its #43 holding.
  • Toronto Dominion Bank first reported a position in Eli Lilly in Q2 2013 and has held it in 52 quarters since.
  • Toronto Dominion Bank's Eli Lilly position peaked at $413M in Q4 2025.
  • 4,356 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Toronto Dominion Bank's 13F filing for Q1 2026, filed 15 May 2026.